Brief: Elicera Therapeutics Q3 Adjusted EPS SEK -0.16
14/11/2023 07:12
Nov 14 (Reuters) - Elicera Therapeutics Q3 adjusted EPS SEK -0.16
Recent news on Elicera Therapeutics AB
See all newsBrief: Nomination Committee Proposes Margareth Jorvid As Chair Of Elicera Board
Brief: Elicera Therapeutics Carries Out Rights Issue Of About SEK 73 Mln
Sweden's Elicera Therapeutics Q1 loss narrows, reports positive clinical progress
Brief: Elicera Therapeutics Q1 Operating Loss SEK 5.1 Mln
Brief: Elicera Therapeutics Gets Notice Of Allowance For Japanease Patent